about
Crystal structure of human aquaporin 4 at 1.8 A and its mechanism of conductanceThe blood-spinal cord barrier: morphology and clinical implicationsGreatly attenuated experimental autoimmune encephalomyelitis in aquaporin-4 knockout micePatterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder.Visual field defects of optic neuritis in neuromyelitis optica compared with multiple sclerosisImmunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica.Experimental models of neuromyelitis optica.Identification of peptide targets in neuromyelitis optica.Identification of two major conformational aquaporin-4 epitopes for neuromyelitis optica autoantibody binding.Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitisUpdate on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).Model of aquaporin-4 supramolecular assembly in orthogonal arrays based on heterotetrameric association of M1-M23 isoforms.Development of a Novel Ligand, [C]TGN-020, for Aquaporin 4 Positron Emission Tomography ImagingDetection of Antibodies against Human and Plant Aquaporins in Patients with Multiple Sclerosis.Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporterAquaporin 4 molecular mimicry and implications for neuromyelitis optica.Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disordersHuman aquaporin 4281-300 is the immunodominant linear determinant in the context of HLA-DRB1*03:01: relevance for diagnosing and monitoring patients with neuromyelitis optica.EFNS guidelines on diagnosis and management of neuromyelitis optica.Neuromyelitis Optica-AQP4: an update.Molecular dynamics of water in the neighborhood of aquaporins.Pathogenic T cell responses against aquaporin 4.Aquaporin-4 deficiency attenuates acute lesions but aggravates delayed lesions and microgliosis after cryoinjury to mouse brain.Aggravated inflammation and increased expression of cysteinyl leukotriene receptors in the brain after focal cerebral ischemia in AQP4-deficient miceGastroparesis as the Sole Presenting Feature of Neuromyelitis Optica.Fluoxetin upregulates connexin 43 expression in astrocyte.Concomitant neuromyelitis optica and cytomegalovirus-associated retinitis in an immunocompetent female.Perinodal glial swelling mitigates axonal degradation in a model of axonal injury.Aquaporin Protein-Protein Interactions.Pseudotumor Cerebri and Glymphatic Dysfunction.Modifications to the McDonald MRI dissemination in space criteria for use in Asians with classic multiple sclerosis: the Taiwanese experience.Computing osmotic permeabilities of aquaporins AQP4, AQP5, and GlpF from near-equilibrium simulations.Combination Treatment of C16 Peptide and Angiopoietin-1 Alleviates Neuromyelitis Optica in an Experimental Model.
P2860
Q24648744-F76082B3-E8BC-4EDB-B353-F5D8B5873E5DQ28240807-2383059F-25A7-4149-8CD9-2F6E2ACDAC79Q30503343-B467A90E-6DF3-4CBC-8338-74645358636AQ33576962-F7E7314E-F51F-4EAA-ACB6-4212EB77FB6FQ33592132-00BBAD75-4802-4C80-8498-6B36EE173663Q33611158-4642C744-8B61-48A7-A5BE-401AD0E6D840Q33769028-8987F920-5DFA-42D1-93B2-8DB53CC51DD9Q33785380-27E489DD-949A-44FE-9C80-F1AD19612D88Q33914842-8E182559-A6DE-49D6-9C6B-0F02300A9596Q34685499-BBFE80BD-0285-4F68-91A8-C7FF7F6CE73FQ34911293-47940E67-0A33-4409-8BBE-16A6D0614E89Q35052199-DB060CC2-A975-4575-A757-9634A832124EQ35070474-254558FE-6E57-4C3D-B0EC-63DB903188CBQ35406026-CB16C97A-5667-452E-A244-513E2D2C4AA8Q35930876-AE053167-DEC0-40EA-A8EE-D0CBFB24F338Q36117107-4D163415-8E7D-47F5-8B56-D9B60CA98550Q36929281-027C6D9C-993B-4E87-A3D4-2383ADF1E79BQ37059594-63765E87-FE20-49F1-81D3-2FC1282E45B4Q37401430-AD3673A6-DA34-4446-ACBB-2388B1BDE6B3Q37763266-EA0610ED-7EA6-4829-B09C-3EA451A14D04Q37933091-DAD05B9D-9EAE-4924-B23A-BF73799C0A5DQ38070349-E63F7EEE-FCDA-4554-AB7C-2E049DAABE58Q39563633-0CB5B987-BE42-4572-80D2-E1868263B47CQ41441907-7B9AEC29-E0FA-44BA-AF27-0904FF58D79AQ41452642-AC2AB42B-059D-4161-AE57-F25ABFF1CB39Q42365392-136935BF-4A69-435E-B68C-01FE3BA9EE16Q42951176-61658915-BD0C-48DD-BD6F-8A0CD54DBE5DQ45987282-6A2E1E14-6968-4CD9-BB5A-61D3A2375184Q46427894-A5723EF9-8B67-484C-96D6-66A956BF868BQ47108955-F56BD3ED-CA3B-4792-8557-5615B6F188F1Q47693607-5F0F263A-96D8-4334-B76A-2E9777A4DE90Q48106929-FFDE28B1-0D20-461F-9423-90EEDDE04A86Q48507949-A2FAB59A-4EA2-4EA5-8918-6AE8764B2D28Q55042761-B343CB2B-1EA9-417C-A1D1-F47C122CE446
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Neuromyelitis optica pathogenesis and aquaporin 4
@ast
Neuromyelitis optica pathogenesis and aquaporin 4
@en
Neuromyelitis optica pathogenesis and aquaporin 4
@en-gb
Neuromyelitis optica pathogenesis and aquaporin 4
@nl
type
label
Neuromyelitis optica pathogenesis and aquaporin 4
@ast
Neuromyelitis optica pathogenesis and aquaporin 4
@en
Neuromyelitis optica pathogenesis and aquaporin 4
@en-gb
Neuromyelitis optica pathogenesis and aquaporin 4
@nl
prefLabel
Neuromyelitis optica pathogenesis and aquaporin 4
@ast
Neuromyelitis optica pathogenesis and aquaporin 4
@en
Neuromyelitis optica pathogenesis and aquaporin 4
@en-gb
Neuromyelitis optica pathogenesis and aquaporin 4
@nl
P2093
P2860
P921
P3181
P356
P1476
Neuromyelitis optica pathogenesis and aquaporin 4
@en
P2093
David J Graber
Douglas Kerr
Michael Levy
William F Wade
P2860
P2888
P3181
P356
10.1186/1742-2094-5-22
P407
P5008
P577
2008-05-29T00:00:00Z
P5875
P6179
1016708605